Oppenheimer Asset Management Inc. Decreases Stock Holdings in HCA Healthcare, Inc. $HCA

Oppenheimer Asset Management Inc. lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.7% in the second quarter, HoldingsChannel reports. The firm owned 4,154 shares of the company’s stock after selling 160 shares during the period. Oppenheimer Asset Management Inc.’s holdings in HCA Healthcare were worth $1,591,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. ORG Partners LLC boosted its position in HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the last quarter. Avantax Advisory Services Inc. boosted its holdings in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after buying an additional 32 shares during the last quarter. Glenview Trust co raised its position in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC grew its position in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after acquiring an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its holdings in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of a number of analyst reports. Morgan Stanley set a $425.00 price target on HCA Healthcare in a research report on Monday. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Stephens upped their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday. TD Cowen lifted their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday. Finally, Raymond James Financial set a $525.00 price target on HCA Healthcare in a report on Monday. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Stock Performance

HCA stock opened at $466.44 on Friday. The firm has a market cap of $109.14 billion, a PE ratio of 18.03, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40. The firm has a fifty day moving average price of $420.00 and a 200 day moving average price of $385.66. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $478.19.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the business earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.